Patent US3818017A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3818017A Expired / Lapsed US ⏱️ 0.0 years remaining

1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds

Assignee: Janssen Pharmaceutica NV
•
Filing: 1973-01-04
•
Granted: 1974-06-18
•
Expires: 1993-01-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds of the class of 1-(1-(2-hydroxy-3-aryloxypropyl)-4piperidyl)- and 1-(1,2,3,6-tetrahydro-1-(2-hydroxy-3aryloxypropyl)-4-pyridyl)-2 -benzimidazolinones, useful as antihypertensive agents.

Inventors

  • 👤 Janssen P Jan
  • 👤 Ineke Wijngaarden Van
  • 👤 W Soudijn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 23:46
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; C07D303/00; C07D303/02; C07D303/12; C07D303/18; C07D303/20; C07D303/24

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 15 words
A chemical compound selected from the group consisting of a benzimidazoline derivative having the formula:
Claim 2
Dependent Claim 15 words
A chemical compound selected from the group consisting of a benzimidazoline derivative having the formula:
Claim 3
Dependent Claim 17 words
A compound selected from the group consisting of 1-(1-(2-hydroxy-3-phenoxypropyl)-4-piperidyl)-2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 4
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-acetylphenoxy)-2-hydroxypropyl)-4-piperidyl) 2-benzimidazolinone -2-benzimidazolinone the therapeutically active acid addition salts thereof.
Claim 5
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(2-hydroxy-3-(o-methoxyphenoxy)propyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 6
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-allyloxyphenoxy)-2-hydroxypropyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 7
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(2-hydroxy-3-(o-(2-propynyloxy)phenoxy)propyl)-4-piperidyl)-2 -benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 8
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(2-hydroxy-3-(o-phenoxyphenoxy)propyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 9
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(4-allyl-2-methoxyphenoxy)-2-hydroxypropyl)-4-piperidyl)-2 -benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 10
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-ethoxyphenoxy)-2-hydroxypropyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 11
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(p-chlorophenoxy)-2-hydroxypropyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 12
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-chlorophenoxy)-2-hydroxypropyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 13
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-butoxyphenoxy)-2-hydroxypropyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 14
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-butyrylphenoxy)-2-hydroxypropyl)-4-piperidyl) -2-benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 15
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1,2,3,6-tetrahydro-1-(2-hydroxy-3-phenoxypropyl)-4-pyridyl)-2 -benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 16
Dependent Claim 18 words
A compound selected from the group consisting of 1-(1-(3-(o-acetylphenoxy)-2-hydroxypropyl)-1,2,3,6-tetrahydro-4-pyridyl)-2 -benzimidazolinone and the therapeutically active acid addition salts thereof.
Claim 17
Dependent Claim 17 words
A compound selected from the group consisting of 1-(1,2,3,6-tetrahydro-1-(2-hydroxy-3-(o-methoxyphenoxy)-propyl)-4-pyridyl)-2-benzimidazolinone and the therapeutically active acid addition salts thereof.

References Cited (Backward Citations)

US3161645A Cited
US3225052A Cited
US3345364A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1977-06-17 1977-12-17 1978-06-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1981-06-17 1981-12-17 1982-06-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1985-06-17 1985-12-17 1986-06-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag